QP 20 - GU 9: Quick Pitch: Predictive Markers in Prostate Cancer

Presentations

• 08:00am - 08:05am PT

  Introduction

  Speaker: David Miyamoto, MD, PhD - Massachusetts General Hospital, Boston
• 08:05am - 08:10am PT

  Germline Indicators of Radiation Therapy Response in Both Aggressive and Non-Aggressive Prostate Cancer Subtypes

  Speaker: David Miyamoto, MD, PhD - Massachusetts General Hospital, Boston
• 08:10am - 08:15am PT

  Prognostic Value of Quantitative Imaging Metrics Obtained in Routine Clinical Practice in a Cohort of Patients Treated with PSMA-RLT

  Speaker: John Floberg, MD, PhD - University of Wisconsin School of Medicine and Public Health, Madison
• 08:15am - 08:20am PT

  Discordance of Adverse Molecular Features between the 22-Gene Genomic Classifier Score, Histologic Grade, and NCCN Risk Groups: Analysis of Over 200,000 Patients

  Speaker: Angela Jia, MD, PhD - University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland
• 08:20am - 08:25am PT

  Validation of a Prognostic Multimodal Artificial Intelligence (MMAI) Model in Asian Prostate Cancer (PCa) Patients (pts) from Singapore

  Speaker: Melvin Lee Kiang Chua, MD, PhD - National Cancer Centre Singapore, Singapore
• 08:25am - 08:30am PT

  Post-Treatment ctDNA Alterations as Predictors of Response to ¹⁷⁷Lu-PSMA in Metastatic Castration-Resistant Prostate Cancer

  Speaker: Opeoluwa Akerele, BS - Tulane University School of Medicine, New Orleans
• 08:30am - 08:35am PT

  Evaluating Molecular Response Using ⁶⁸Ga-PSMA-PET/CT in Prostate Cancer Patients with Pelvic Lymph Node Metastasis Undergoing Definitive Radiotherapy: Clinical Significance and Implications

  Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana
• 08:35am - 08:55am PT

  Question and Answers

  Speaker: Sean Sachdev, MD - Northwestern University, Chicago
• 08:55am - 09:00am PT

  Closing

  Speaker: David Miyamoto, MD, PhD - Massachusetts General Hospital, Boston